Celon Pharma S.A. received an award for the best stock debut in 2016

Celon Pharma S.A. was presented with the “Bulls and Bears” ("Byki i Niedźwiedzie") award in the category “Debut of the year” – the oldest and most important award given to listed companies.

The stock debut was one of the most important events of last year for us. We feel honoured that the jury of Bulls and Bears and the Warsaw Stock Exchange “Parkiet” Newspaper have appreciated our effort, thanks to which we are now among other distinguished, prestigious companies – said Maciej Wieczorek, President of the Management Board at Celon Pharma S.A.

Celon Pharma S.A. debuted on the Warsaw Stock Exchange in October 2016. Its share price increased by 17.58% already during the first day.

This success resulted from the work of many people and teams – employees at Celon Pharma S.A., our advisers and partners. It would not be possible without the trust put in us by the investors who decided to buy our shares. This award obliges us to continue the implementation of our business strategy every single day, including the development and commercialisation of projects which will address major clinical challenges – adds Maciej Wieczorek, President of the Board at Celon Pharma S.A.

 “Bulls and Bears” are awarded annually by the Warsaw Stock Exchange “Parkiet” Newspaper to listed companies, as well as capital market institutions and organisers. The awards aim at promoting institutions and professionals who contribute to the development, popularisation and expansion of the capital market.

Tweet about this on TwitterShare on LinkedInShare on FacebookShare on Google+